SCHEMBL7948231

SCHEMBL7948231

CSc1cccc(Cl)c1I

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 5/20 0.41
ALDH1A1 P00352 5/20 0.41
P2RX7 Q99572 2/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2A6 P11509 1/20 0.35
KDM4E B2RXH2 3/20 0.34
HPGD P15428 3/20 0.34
LMNA P02545 2/20 0.33
TSHR P16473 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
STK10 O94804 1/20 0.33
SLK Q9H2G2 1/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4517035 0.83 ALDH1A1 (0.33) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL171713 0.77
SCHEMBL1146294 0.76 MAPT (0.53) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL9396238 0.76 IDO1 (0.33) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL255293 0.75
SCHEMBL31336772 0.75
SCHEMBL3788212 0.74 MAPT (0.43) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL22121949 0.74 CYP1A2 (0.36) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL30523308 0.74 CYP1A2 (0.36) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL4030686 0.74 MAPT (0.54) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260096277-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME LT MATERIALS CO., LTD. (KR) 2026-04-02 US disclosed
CN-120051462-A Heterocyclic compound and organic light-emitting device comprising same LT素材株式会社 2025-05-27 CN disclosed
CN-119977939-A Synthesis method of 1, 9-dihalogenated dibenzothiophene derivative 西安欧得光电材料有限公司 2025-05-13 CN disclosed
US-6265606-B1 TO CONTROL A BROAD SPECTRUM OF UNDESIRABLE VEGETATION, ARE SELECTIVE TO MAJOR CROPS, HAVE DESIRABLE ENVIRONMENTAL PROFILES, DOW AGROSCIENCES LLC 2001-07-24 US disclosed
US-6010981-A 1-alkyl-4-benzoyl-5-hydroxypyrazole compounds and their use as herbicides DOW AGROSCIENCES LLC (US) 2000-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260096277-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME CYP1A1, CYP1B1, CHRM1 MAPT 3191/4885MEN1 187/4885KMT2A 3087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.